Please use this identifier to cite or link to this item:
https://hdl.handle.net/10356/146977
Title: | A deep neural network approach to predicting clinical outcomes of neuroblastoma patients | Authors: | Tranchevent, Léon-Charles Azuaje, Francisco Rajapakse, Jagath Chandana |
Keywords: | Science::Biological sciences | Issue Date: | 2019 | Source: | Tranchevent, L., Azuaje, F. & Rajapakse, J. C. (2019). A deep neural network approach to predicting clinical outcomes of neuroblastoma patients. BMC Medical Genomics, 12(Suppl 8). https://dx.doi.org/10.1186/s12920-019-0628-y | Journal: | BMC Medical Genomics | Abstract: | Background: The availability of high-throughput omics datasets from large patient cohorts has allowed the development of methods that aim at predicting patient clinical outcomes, such as survival and disease recurrence. Such methods are also important to better understand the biological mechanisms underlying disease etiology and development, as well as treatment responses. Recently, different predictive models, relying on distinct algorithms (including Support Vector Machines and Random Forests) have been investigated. In this context, deep learning strategies are of special interest due to their demonstrated superior performance over a wide range of problems and datasets. One of the main challenges of such strategies is the "small n large p" problem. Indeed, omics datasets typically consist of small numbers of samples and large numbers of features relative to typical deep learning datasets. Neural networks usually tackle this problem through feature selection or by including additional constraints during the learning process. Methods: We propose to tackle this problem with a novel strategy that relies on a graph-based method for featureextraction, coupled with a deep neural network for clinical outcome prediction. The omics data are first representedas graphs whose nodes represent patients, and edges represent correlations between the patients’ omics profiles.Topological features, such as centralities, are then extracted from these graphs for every node. Lastly, these featuresare used as input to train and test various classifiers. Results: We apply this strategy to four neuroblastoma datasets and observe that models based on neural networksare more accurate than state of the art models (DNN: 85%-87%, SVM/RF: 75%-82%). We explore how differentparameters and configurations are selected in order to overcome the effects of the small data problem as well as thecurse of dimensionality. Conclusions: Our results indicate that the deep neural networks capture complex features in the data that helppredicting patient clinical outcomes. | URI: | https://hdl.handle.net/10356/146977 | ISSN: | 1755-8794 | DOI: | 10.1186/s12920-019-0628-y | Schools: | School of Computer Science and Engineering | Research Centres: | Bioinformatics Research Centre | Rights: | © 2019 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | Fulltext Permission: | open | Fulltext Availability: | With Fulltext |
Appears in Collections: | SCSE Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s12920-019-0628-y.pdf | 1.23 MB | Adobe PDF | ![]() View/Open |
SCOPUSTM
Citations
20
19
Updated on Mar 24, 2025
Web of ScienceTM
Citations
20
11
Updated on Oct 29, 2023
Page view(s)
298
Updated on Mar 26, 2025
Download(s) 50
109
Updated on Mar 26, 2025
Google ScholarTM
Check
Altmetric
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.